CYTOSORBENTS CORPORATION Total Long-Term Debt
CYTOSORBENTS CORPORATION (CTSO) had Total Long-Term Debt of $17.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-06
- 2026-06-30: Long-term Debt $17.24M.
- 2026-03-31: Long-term Debt $16.96M.
- 2025-12-31: Long-term Debt $16.67M.
- 2024-09-30: Long-term Debt $13.81M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $17.24M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $16.96M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $16.67M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $13.81M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $13.67M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.43M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.04M 10-K · filed 2024-03-15 |
| 2023-09-30 | $5.03M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.02M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $5.01M 10-Q · filed 2023-05-02 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-09 |
| 2020-09-30 | $15.16M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $15.12M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $15.09M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $15.05M 10-K · filed 2021-03-09 |
| 2019-09-30 | $15.02M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $9.99M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $9.96M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $9.94M 10-K · filed 2020-03-05 |
| 2018-09-30 | $9.92M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $9.89M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $9.87M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $9.99M 10-K · filed 2019-03-07 |
| 2017-09-30 | $9.97M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $9.94M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.93M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $4.91M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $4.90M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $5.00M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |